CN107320522A - Chinese medicine composition and preparation method are grown for bird immunity - Google Patents
Chinese medicine composition and preparation method are grown for bird immunity Download PDFInfo
- Publication number
- CN107320522A CN107320522A CN201710560002.XA CN201710560002A CN107320522A CN 107320522 A CN107320522 A CN 107320522A CN 201710560002 A CN201710560002 A CN 201710560002A CN 107320522 A CN107320522 A CN 107320522A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- traditional chinese
- group
- poultry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 84
- 239000000203 mixture Substances 0.000 title claims abstract description 67
- 238000002360 preparation method Methods 0.000 title claims abstract description 6
- 230000036039 immunity Effects 0.000 title claims description 7
- 229940079593 drug Drugs 0.000 claims abstract description 13
- 235000014134 echinacea Nutrition 0.000 claims abstract description 9
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 8
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 7
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 241000218628 Ginkgo Species 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 4
- 241000258180 Echinacea <Echinodermata> Species 0.000 claims 2
- 238000001914 filtration Methods 0.000 claims 2
- 239000009636 Huang Qi Substances 0.000 claims 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 claims 1
- 238000007654 immersion Methods 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 claims 1
- 235000021286 stilbenes Nutrition 0.000 claims 1
- 244000144977 poultry Species 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 13
- 230000004584 weight gain Effects 0.000 abstract description 12
- 235000019786 weight gain Nutrition 0.000 abstract description 12
- 241001061264 Astragalus Species 0.000 abstract description 9
- 235000006533 astragalus Nutrition 0.000 abstract description 9
- 238000006243 chemical reaction Methods 0.000 abstract description 9
- 210000004233 talus Anatomy 0.000 abstract description 9
- 239000003623 enhancer Substances 0.000 abstract description 8
- 208000035240 Disease Resistance Diseases 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 7
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract description 6
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 6
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract description 6
- 229940010454 licorice Drugs 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 5
- 239000003640 drug residue Substances 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 240000004530 Echinacea purpurea Species 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 3
- 244000194101 Ginkgo biloba Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 description 32
- 235000013330 chicken meat Nutrition 0.000 description 31
- 238000001514 detection method Methods 0.000 description 24
- 235000013594 poultry meat Nutrition 0.000 description 18
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical group C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 15
- 210000002966 serum Anatomy 0.000 description 14
- 210000000952 spleen Anatomy 0.000 description 11
- 241001260012 Bursa Species 0.000 description 10
- 101001066878 Homo sapiens Polyribonucleotide nucleotidyltransferase 1, mitochondrial Proteins 0.000 description 8
- 102100034410 Polyribonucleotide nucleotidyltransferase 1, mitochondrial Human genes 0.000 description 8
- 102100037850 Interferon gamma Human genes 0.000 description 7
- 108010074328 Interferon-gamma Proteins 0.000 description 7
- 108090000978 Interleukin-4 Proteins 0.000 description 7
- 108090001005 Interleukin-6 Proteins 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 108010065805 Interleukin-12 Proteins 0.000 description 6
- 241000202807 Glycyrrhiza Species 0.000 description 5
- 241000702626 Infectious bursal disease virus Species 0.000 description 5
- 244000133098 Echinacea angustifolia Species 0.000 description 4
- 230000007969 cellular immunity Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 230000004727 humoral immunity Effects 0.000 description 4
- 210000004698 lymphocyte Anatomy 0.000 description 4
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
- 239000001685 glycyrrhizic acid Substances 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical group O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 238000002255 vaccination Methods 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108010002350 Interleukin-2 Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000003674 animal food additive Substances 0.000 description 2
- QMNWISYXSJWHRY-YLNUDOOFSA-N astragaloside IV Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)[C@H]4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)C[C@H]3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-YLNUDOOFSA-N 0.000 description 2
- QMNWISYXSJWHRY-BCBPIKMJSA-N astragaloside IV Natural products CC(C)(O)[C@@H]1CC[C@@](C)(O1)[C@H]2[C@@H](O)C[C@@]3(C)[C@@H]4C[C@H](O[C@@H]5O[C@H](CO)[C@H](O)[C@@H](O)[C@H]5O)[C@H]6C(C)(C)[C@H](CC[C@@]67C[C@@]47CC[C@]23C)O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O QMNWISYXSJWHRY-BCBPIKMJSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- PFKIBRPYVNVMRU-UHFFFAOYSA-N cyclosieversioside F Natural products CC(C)(O)C1COC(C)(C1)C2C(O)CC3(C)C4CC(OC5OC(CO)C(O)C(O)C5O)C6C(C)(C)C(CCC67CC47CCC23C)OC8OCC(O)C(O)C8O PFKIBRPYVNVMRU-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 210000002865 immune cell Anatomy 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- YDDGKXBLOXEEMN-UHFFFAOYSA-N Di-E-caffeoyl-meso-tartaric acid Natural products C=1C=C(O)C(O)=CC=1C=CC(=O)OC(C(O)=O)C(C(=O)O)OC(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 108090000174 Interleukin-10 Proteins 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 208000010359 Newcastle Disease Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002391 anti-complement effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002019 anti-mutation Effects 0.000 description 1
- 108010008730 anticomplement Proteins 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- -1 bacteriostats Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- YDDGKXBLOXEEMN-IABMMNSOSA-N chicoric acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-IABMMNSOSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical group O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000006193 cichoric acid Nutrition 0.000 description 1
- 229930016920 cichoric acid Natural products 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- YDDGKXBLOXEEMN-WOJBJXKFSA-N dicaffeoyl-L-tartaric acid Natural products O([C@@H](C(=O)O)[C@@H](OC(=O)C=CC=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)C=CC1=CC=C(O)C(O)=C1 YDDGKXBLOXEEMN-WOJBJXKFSA-N 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 230000000091 immunopotentiator Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229960001614 levamisole Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000001937 non-anti-biotic effect Effects 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000013613 poultry product Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000005201 spleen development Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical class OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 150000008135 α-glycosides Chemical group 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fodder In General (AREA)
Abstract
一种用于禽类免疫生长中药组合物及制备方法,由紫锥菊、黄芪、银杏果肉、金银花、甘草组成,中药组合物在禽类自由饮水中按水量的4%浓度添加。可以克服化学药物免疫增强剂存在的降低机体生产性能,引发毒副作用和药物残留,危害人体健康等弊端。用于禽类免疫生长中药组合物不仅可提高机体的抗病力和抵抗力,而且能够提高禽类的增重和饲料转化率,产生良好的经济效益。A traditional Chinese medicine composition for poultry immune growth and a preparation method thereof, which is composed of echinacea purpurea, astragalus, ginkgo pulp, honeysuckle, and licorice. It can overcome the disadvantages of reducing the production performance of the body, causing toxic side effects and drug residues, and endangering human health in the presence of chemical drug immune enhancers. The traditional Chinese medicine composition used for poultry immune growth can not only improve the disease resistance and resistance of the body, but also can improve the weight gain and feed conversion rate of the poultry, and produce good economic benefits.
Description
技术领域:Technical field:
本发明涉及一种用于禽类免疫生长中药组合物,在禽类饲养中应用,禽饮用后可以增加脾脏、法氏囊指数,NDV-Ⅳ、IBDV抗体的合成,鸡血清IL-6、IFN-γ、IL-4和IL-12的含量,提高增重和饲料转化率。The invention relates to a traditional Chinese medicine composition for poultry immune growth, which is used in poultry feeding, and can increase spleen and bursa index, synthesis of NDV-IV and IBDV antibodies, chicken serum IL-6 and IFN-γ after drinking. , IL-4 and IL-12 content, increase weight gain and feed conversion rate.
技术背景:technical background:
近年来,在养鸡生产中普遍存在疫苗免疫接种效果不佳的问题,这是由于长期以来大量的滥用药物及不合理的疫苗接种而导致鸡体免疫功能下降,特别是淋巴细胞等免疫细胞处于低迷或抑制状态。加之近年来新的疫病不断出现,旧的疫病的病原体变异和毒力增强,使得鸡传染病不断发作。要解决这一问题,就必须采取有效手段激活免疫系统,提高免疫细胞的活性,以使鸡体接种疫苗后获得较高水平的免疫应答,增强机体的抗病能力。目前使用的化学药物免疫增强剂对养鸡业的健康发展起到了积极的作用,但是化学药物免疫增强剂都不同程度的存在着降低机体生产性能,引发毒副作用和药物残留,危害人体健康等弊端。中药具有低毒少残留的优势,因此,寻求中药作为免疫增强剂不仅可提高机体的抗病力和抵抗力,而且能够提高禽类的增重和饲料转化率,产生良好的经济效益。In recent years, there is a common problem of poor vaccination effect in chicken production. This is due to the long-term abuse of a large number of drugs and unreasonable vaccination, which leads to the decline of immune function of chickens, especially the immune cells such as lymphocytes. Depressed or depressed state. In addition, new epidemic diseases continue to appear in recent years, and the pathogenic mutation and virulence of old epidemic diseases are enhanced, which makes chicken infectious diseases continue to break out. To solve this problem, it is necessary to take effective measures to activate the immune system and improve the activity of immune cells, so that the chicken body can obtain a higher level of immune response after vaccination and enhance the body's disease resistance. The currently used chemical drug immune enhancers have played a positive role in the healthy development of the chicken industry, but the chemical drug immune enhancers all have disadvantages such as reducing the production performance of the body to varying degrees, causing toxic side effects and drug residues, and endangering human health. . Traditional Chinese medicine has the advantages of low toxicity and less residue. Therefore, seeking Chinese medicine as an immune enhancer can not only improve the body's disease resistance and resistance, but also improve the weight gain and feed conversion rate of poultry, resulting in good economic benefits.
发明内容:Invention content:
本发明的目的,是克服上述的缺陷,提供一种不仅可提高禽类的抗病力和抵抗力,而且能够提高禽类的增重和饲料转化率,成本低廉、毒副作用小的用于禽类免疫生长中药组合物及制备方法。The purpose of the present invention is to overcome the above-mentioned defects, to provide a kind of immunogrowth for poultry that can not only improve the disease resistance and resistance of poultry, but also can improve the weight gain and feed conversion rate of poultry, with low cost and little toxic and side effects. Traditional Chinese medicine composition and preparation method.
本发明是通过以下技术途径来实现的:The present invention is achieved through the following technical approaches:
本发明的用于禽类免疫生长中药组合物,按质量份数组成:紫锥菊30~50、黄芪15~25、银杏果肉15~25、金银花8~12、甘草8~12。其制备方法是:The traditional Chinese medicine composition for poultry immune growth of the present invention consists of 30-50 parts by mass of echinacea, 15-25 parts of astragalus, 15-25 parts of ginkgo pulp, 8-12 parts of honeysuckle and 8-12 parts of licorice. Its preparation method is:
按质量份数,取紫锥菊30~50、黄芪15~25、银杏果肉15~25、金银花8~12、甘草8~12,上述5种中药切碎处理80-100目,按材料总质量10倍的蒸馏水浸泡12-18小时,然后煮沸2 h 后过滤,收集滤液;其滤渣加5 倍量蒸馏水煮沸2 h后过滤,收集滤液,两次滤液合并,浓缩成每mL含药物1g的药液。According to the number of parts by mass, take 30-50 pieces of echinacea, 15-25 pieces of astragalus, 15-25 pieces of ginkgo pulp, 8-12 pieces of honeysuckle, and 8-12 pieces of licorice. Soak in distilled water for 12-18 hours, then boil for 2 hours, filter, and collect the filtrate; add 5 times the amount of distilled water to the filter residue, boil for 2 hours, filter, collect the filtrate, combine the two filtrates, and concentrate to a drug solution containing 1g of drug per mL.
用法与用量:Usage and Dosage:
中药组合物在禽类自由饮水中按水量的4%浓度添加。The traditional Chinese medicine composition is added in the free drinking water of poultry according to the concentration of 4% of the water volume.
本发明所用的中草药原料均可从中医药店和医药公司购得,其规格符合国家医药标准。The Chinese herbal medicine raw materials used in the present invention can be purchased from traditional Chinese medicine stores and pharmaceutical companies, and its specifications meet the national medical standards.
本发明的上述中药组合物加入适宜附加剂(常用的有矫味剂、抑菌剂、抗氧化剂、着色剂等),溶解混匀,滤过澄清,可制备成一种常用的口服制剂,例如口服液等。The above traditional Chinese medicine composition of the present invention can be prepared into a commonly used oral preparation by adding appropriate additives (commonly used flavoring agents, bacteriostats, antioxidants, coloring agents, etc.), dissolved and mixed, filtered and clarified, such as oral liquid etc.
本发明的效益:Benefits of the present invention:
1.生产高品质、低药物残留、绿色无公害禽类产品1. Produce high-quality, low drug residue, green and pollution-free poultry products
近年来,化药免疫增强剂的研究取得了较大的进展,对养鸡业的健康发展起到了积极的作用,但是化学药物免疫增强剂都不同程度的存在着降低机体生产性能,引发毒副作用和药物残留,危害人体健康等弊端。而中药免疫增强剂因其天然性、作用广泛、标本兼治、安全低毒、不易产生耐药性、无污染、无残留等特点而备受关注。本发明中药组合物不仅可提高机体的抗病力和抵抗力,而且能够提高禽类的增重和饲料转化率,产生良好的经济效益。In recent years, the research of chemical drug immune enhancers has made great progress, which has played a positive role in the healthy development of the chicken industry, but chemical drug immune enhancers all exist to varying degrees to reduce the production performance of the body and cause toxic and side effects and drug residues, endangering human health and other disadvantages. Traditional Chinese medicine immune enhancers have attracted much attention because of their naturalness, wide range of effects, treating both symptoms and root causes, safety and low toxicity, not easy to produce drug resistance, no pollution, and no residue. The traditional Chinese medicine composition of the invention can not only improve the disease resistance and resistance of the body, but also can increase the weight gain and feed conversion rate of poultry, and produce good economic benefits.
2.提高禽类的抗病力和抵抗力2. Improve the disease resistance and resistance of poultry
本发明中药组合物突出特点是组合物中含有紫锥菊、黄芪、银杏果肉、金银花、甘草。5种中药原料按质量份数组成中药组合物,能够产生协同作用刺激禽类机体免疫应答,增强免疫功能而增进疗效。禽类免疫生长中药组合物,具有补气升阳,补脾益气,补虚扶正,敛肺气、定喘嗽,缓和药性,清热解毒,调和诸药,消炎、抗菌的作用。禽饮用后可以增加脾脏、法氏囊指数,NDV-Ⅳ、IBDV抗体的合成,鸡血清IL-6、IFN-γ、IL-4和IL-12的含量,提高增重和饲料转化率。The prominent feature of the traditional Chinese medicine composition of the invention is that the composition contains echinacea purpurea, astragalus, ginkgo pulp, honeysuckle and licorice. The traditional Chinese medicine composition composed of five kinds of traditional Chinese medicine raw materials can produce synergistic effect to stimulate the immune response of poultry body, enhance the immune function and improve the curative effect. The poultry immune growth traditional Chinese medicine composition has the functions of invigorating qi and promoting yang, invigorating spleen and qi, invigorating deficiency and strengthening the body, astringing lung qi, relieving asthma and cough, alleviating medicinal properties, clearing heat and detoxifying, harmonizing various medicines, anti-inflammatory and antibacterial effects. After poultry drinking, it can increase spleen, bursa index, NDV-Ⅳ, IBDV antibody synthesis, chicken serum IL-6, IFN-γ, IL-4 and IL-12 content, increase weight gain and feed conversion rate.
紫锥菊主要成份菊苣酸。菊苣酸为咖啡酸衍生物,是紫锥菊中极为重要的免疫活性成分之一。紫锥菊具有增强免疫、抗炎、抗感染等功效。The main ingredient of Echinacea is cichoric acid. Chichoric acid is a derivative of caffeic acid and is one of the most important immune active components in Echinacea purpurea. Echinacea has the functions of enhancing immunity, anti-inflammation, and anti-infection.
黄芪主要成份黄芪甲甙和黄芪多糖。黄芪甲甙能促进淋巴结B细胞增殖分化和浆细胞抗体形成。黄芪多糖能增强吞噬细胞的吞噬功能,增加脾及胸腺重量。黄芪对正常机体的抗体生成功能有明显促进作用。黄芪具有增强免疫力,增强能量,抗疲劳,抗突变,保肝,抑制破骨细胞的作用。The main components of Astragalus are astragaloside IV and astragalus polysaccharide. Astragaloside IV can promote the proliferation and differentiation of lymph node B cells and the formation of plasma cell antibodies. Astragalus polysaccharides can enhance the phagocytosis of phagocytes and increase the weight of spleen and thymus. Astragalus can significantly promote the antibody production function of the normal body. Astragalus has the effects of enhancing immunity, enhancing energy, anti-fatigue, anti-mutation, protecting the liver, and inhibiting osteoclasts.
银杏果肉经水提取后,主要成份多糖由葡萄糖、半乳糖、果糖和鼠李糖组成,为α-苷键肽多糖,对禽类细胞免疫和体液免疫功能低下状态有显著调节作用。After the ginkgo pulp is extracted by water, the main component polysaccharides are composed of glucose, galactose, fructose and rhamnose, which are α-glycoside bonded peptidoglycans, which have a significant regulating effect on the hypofunction of cellular immunity and humoral immunity of poultry.
金银花主要成份绿原酸。金银花能调节淋巴细胞的生理功能,显著增加IL-2,使受到抑制的淋巴细胞分泌细胞因子的功能得到调节,能调节特异性细胞免疫、非特异性细胞免疫和特异性体液免疫。金银花具有清热解毒,凉散风热。The main component of honeysuckle is chlorogenic acid. Honeysuckle can regulate the physiological function of lymphocytes, significantly increase IL-2, regulate the function of suppressed lymphocytes secreting cytokines, and can regulate specific cellular immunity, non-specific cellular immunity and specific humoral immunity. Flos Lonicerae has heat-clearing and toxic substances removing, cools away wind-heat.
甘草主要成份甘草酸。甘草酸通过双重调节细胞免疫及体液免疫来发挥作用。甘草酸能够增强辅助性 T 淋巴细胞的增殖能力和活性,促进淋巴细胞产生 IL-2,IFN-γ,IL-1 等细胞因子,抑制 IL-4,IL-10,IL-8 等的生成,同时具有抗补体活性作用。甘草具有补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药的作用。The main ingredient of licorice is glycyrrhizic acid. Glycyrrhizic acid plays a role through dual regulation of cellular immunity and humoral immunity. Glycyrrhizic acid can enhance the proliferation and activity of helper T lymphocytes, promote lymphocytes to produce IL-2, IFN-γ, IL-1 and other cytokines, and inhibit the production of IL-4, IL-10, IL-8, etc. It also has anti-complement activity. Licorice has the functions of invigorating the spleen and replenishing qi, clearing heat and detoxification, eliminating phlegm and relieving cough, relieving spasm and relieving pain, and harmonizing the effects of various medicines.
3.提高禽类的增重和饲料转化率,产生良好的经济效益3. Improve poultry weight gain and feed conversion rate, resulting in good economic benefits
随着我国加入WTO以及我国肉类食品的卫生标准的提高,饲料安全是保证动物类食品安全的基本条件,发展无公害绿色食品也是畜禽养殖当务之急。免疫增强剂是饲料添加剂由抗生素型转向非抗生素型过程中人们普遍关注的新型饲料添加剂。一些免疫增强剂不仅可以有效地提高动物免疫力,而且能起到抗病促生长的作用。本发明禽类免疫生长中药组合物另一突出特点是能够提高禽类的增重和饲料转化率,产生良好的经济效益。With my country's accession to WTO and the improvement of my country's meat food hygiene standards, feed safety is the basic condition to ensure the safety of animal food, and the development of pollution-free green food is also a top priority for livestock and poultry breeding. Immunopotentiator is a new type of feed additive that people generally pay attention to in the process of feed additive from antibiotic type to non-antibiotic type. Some immune enhancers can not only effectively improve animal immunity, but also play a role in disease resistance and growth promotion. Another prominent feature of the traditional Chinese medicine composition for poultry immune growth of the invention is that it can increase the poultry's weight gain and feed conversion rate, and produce good economic benefits.
具体实施方式:detailed description:
以下通过实施例来进一步描述本发明,应该理解的是,这些实施例仅用于例证的目的,决不限制本发明的范围。The present invention is further described by the following examples. It should be understood that these examples are only for the purpose of illustration, and in no way limit the scope of the present invention.
试验例] :Test example]:
1日龄海兰褐商品代蛋鸡公雏,分为对照Ⅰ组,对照Ⅱ组,左旋咪唑组,4%中药组合物组,其中对照组Ⅰ为正常免疫不用药组,对照组Ⅱ为不免疫不用药组。7日龄进行新城疫Ⅳ系接种免疫,13日龄进行法氏囊弱毒苗接种免疫。The 1-day-old Hailan brown commercial laying chickens were divided into control group Ⅰ, control group Ⅱ, levamisole group, and 4% traditional Chinese medicine composition group. Immunization without drug group. At the age of 7 days, the Newcastle disease Ⅳ line was immunized, and at the age of 13, the attenuated bursa vaccine was immunized.
实施例1:4%中药组合物不同时间段脾脏指数的检测结果Example 1: Detection results of spleen index in different time periods of 4% traditional Chinese medicine composition
脾脏指数=脾脏重(mg)/体重(g),不同日龄脾脏指数的检测结果,见表1。4%中药组合物均极显著(P<0.01)高于对照组Ⅰ、Ⅱ和左旋咪唑组,表明4%中药组合物能增加鸡脾脏指数,具有刺激鸡脾脏发育的作用。Spleen index=spleen weight (mg)/body weight (g). The test results of spleen index at different ages are shown in Table 1. The 4% traditional Chinese medicine composition was significantly ( P< 0.01) higher than that of the control group Ⅰ, Ⅱ and levamisole Group, show that 4% Chinese medicine composition can increase chicken spleen index, has the effect of stimulating chicken spleen development.
表1 4%中药组合物不同日龄脾脏指数的检测结果Table 1 Detection results of spleen index of 4% traditional Chinese medicine composition at different ages
实施例2: 4%中药组合物不同时间段法氏囊指数的检测结果Example 2: Detection results of bursa index of 4% traditional Chinese medicine composition in different time periods
法氏囊指数=法氏囊重(mg)/体重(g),不同日龄法氏囊指数的检测结果,见表2。4%中药组合物均极显著(P<0.01)高于对照组Ⅰ、Ⅱ和左旋咪唑组,表明4%中药组合物能增加鸡法氏囊指数,具有刺激鸡法氏囊发育的作用。Bursa index = weight of bursa (mg)/body weight (g). The test results of bursa index at different ages are shown in Table 2. The 4% traditional Chinese medicine composition was significantly ( P< 0.01) higher than that of the control group Groups Ⅰ, Ⅱ and levamisole indicated that the 4% traditional Chinese medicine composition could increase the index of chicken bursa and stimulate the development of chicken bursa.
表2 4%中药组合物不同日龄法氏囊指数的检测结果Table 2 Detection results of bursa index of 4% traditional Chinese medicine composition at different ages
实施例3: 4%中药组合物对NDV-Ⅳ抗体的检测结果Example 3: Detection results of 4% traditional Chinese medicine composition for NDV-IV antibody
不同日龄对NDV-Ⅳ抗体检测结果,见表3。4%中药组合物均极显著(P<0.01)高于对照组Ⅰ、Ⅱ和左旋咪唑组,表明4%中药组合物能提高鸡的体液免疫功能。The results of NDV-IV antibody detection at different ages are shown in Table 3. The 4% traditional Chinese medicine composition was significantly higher ( P< 0.01) than the control group I, II and levamisole group, indicating that the 4% traditional Chinese medicine composition can improve chicken Humoral immune function.
表3 4%中药组合物对不同日龄NDV-Ⅳ抗体的检测结果Table 3 The detection results of 4% traditional Chinese medicine composition on NDV-Ⅳ antibody at different ages
实施例4: 4%中药组合物对IBDV抗体的检测结果Example 4: Detection results of 4% traditional Chinese medicine composition to IBDV antibody
不同日龄对IBDV抗体检测结果,见表3。4%中药组合物均极显著(P<0.01)高于对照组Ⅰ、Ⅱ和左旋咪唑组,表明4%中药组合物能提高鸡的体液免疫功能。The results of IBDV antibody detection at different ages are shown in Table 3. The 4% Chinese medicine composition was significantly higher ( P< 0.01) than the control group I, II and levamisole group, indicating that the 4% Chinese medicine composition can improve the humoral immunity of chickens Function.
表4 4%中药组合物对不同日龄IBDV抗体(log10)的检测结果Table 4 The detection results of 4% traditional Chinese medicine composition to IBDV antibody (log10) at different ages
实施例5:4%中药组合物鸡血清IL-6含量的检测结果Embodiment 5: the detection result of 4% Chinese medicine composition chicken serum IL-6 content
不同日龄鸡血清IL-6含量的检测结果,见表5。4%中药组合物极显著(P<0.01)高于对照组Ⅰ、Ⅱ和左旋咪唑组,表明4%中药组合物能提高鸡IL-6的含量。The detection results of serum IL-6 levels in different day-old chickens are shown in Table 5. The 4% traditional Chinese medicine composition was significantly ( P< 0.01) higher than that in the control group Ⅰ, Ⅱ and levamisole group, indicating that the 4% traditional Chinese medicine composition can increase the level of IL-6 in chickens. IL-6 content.
表5 4%中药组合物对不同日龄鸡血清IL-6含量的检测结果(pg/mL)Table 5 Detection results of 4% traditional Chinese medicine composition on serum IL-6 content of different day-old chickens (pg/mL)
实施例6:4%中药组合物鸡血清IFN-γ含量的检测结果Example 6: Detection results of 4% Chinese medicine composition chicken serum IFN-γ content
不同日龄鸡血清IFN-γ含量的检测结果,见表6。4%中药组合物极显著(P<0.01)高于对照组Ⅰ、Ⅱ和左旋咪唑组,表明4%中药组合物能提高鸡IFN-γ的含量。The detection results of serum IFN-γ levels in different day-old chickens are shown in Table 6. The 4% traditional Chinese medicine composition was significantly ( P< 0.01) higher than that in the control group Ⅰ, Ⅱ and levamisole group, indicating that the 4% traditional Chinese medicine composition can improve chicken The content of IFN-γ.
表6 4%中药组合物对不同日龄鸡血清IFN-γ含量的检测结果(ng/L)Table 6 The detection results of 4% traditional Chinese medicine composition on the serum IFN-γ content of different day-old chickens (ng/L)
实施例7: 4%中药组合物鸡血清IL-4含量的检测结果Example 7: Detection results of 4% Chinese medicine composition chicken serum IL-4 content
不同日龄鸡血清IL-4含量的检测结果,见表7。4%中药组合物极显著(P<0.01)高于对照组Ⅰ、Ⅱ和左旋咪唑组,表明4%中药组合物能提高鸡IL-4的含量。The detection results of serum IL-4 levels in different day-old chickens are shown in Table 7. The 4% traditional Chinese medicine composition was significantly ( P< 0.01) higher than the control group I, II and levamisole group, indicating that the 4% traditional Chinese medicine composition can improve chicken IL-4 content.
表7 4%中药组合物对不同日龄鸡血清IL-4含量的检测结果(ng/L)Table 7 The detection results of 4% traditional Chinese medicine composition on serum IL-4 content of chickens of different ages (ng/L)
实施例8: 4%中药组合物鸡血清IL-12含量的检测结果Example 8: Detection results of 4% traditional Chinese medicine composition chicken serum IL-12 content
不同日龄鸡血清IL-12含量的检测结果,见表7。4%中药组合物极显著(P<0.01)高于对照组Ⅰ、Ⅱ和左旋咪唑组,表明4%中药组合物能提高鸡IL-12的含量。The detection results of serum IL-12 levels in different day-old chickens are shown in Table 7. The 4% traditional Chinese medicine composition was significantly ( P< 0.01) higher than that of the control group I, II and levamisole group, indicating that the 4% traditional Chinese medicine composition can improve chicken IL-12 content.
表8 4%中药组合物对不同日龄鸡血清IL-12含量的检测结果(ng/L)Table 8 Detection results of 4% traditional Chinese medicine composition on serum IL-12 content of different day-old chickens (ng/L)
实施例9:4%中药组合物对不同日龄增重的检测结果Example 9: Detection results of 4% traditional Chinese medicine composition on weight gain at different ages
不同日龄增重检测结果,见表9。4%中药组合物均极显著(P<0.01)高于对照组Ⅰ、Ⅱ和左旋咪唑组,表明4%中药组合物可提高增重。The test results of weight gain at different ages are shown in Table 9. The 4% traditional Chinese medicine composition was significantly ( P< 0.01) higher than that of the control group I, II and levamisole group, indicating that the 4% traditional Chinese medicine composition can increase weight gain.
表9 4%中药组合物对不同日龄增重检测结果(g)Table 9 Test results of 4% traditional Chinese medicine composition on weight gain at different ages (g)
实施例10:4%中药组合物对不同周龄料肉比的检测结果Example 10: Detection results of 4% traditional Chinese medicine composition on feed-to-meat ratio at different ages
不同周龄料肉比的检测结果,见表10。4%中药组合物均极显著(P<0.01)高于对照组Ⅰ、Ⅱ和左旋咪唑组,表明4%中药组合物能提高肉鸡的饲料转化率。The test results of feed-to-meat ratio at different ages are shown in Table 10. The 4% traditional Chinese medicine composition was significantly ( P< 0.01) higher than that of the control group I, II and levamisole group, indicating that the 4% traditional Chinese medicine composition can improve the feed quality of broilers. Conversion rate.
表10 4%中药组合物对不同周龄料肉比的检测结果Table 10 Test results of 4% traditional Chinese medicine composition on feed-to-meat ratio at different ages
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710560002.XA CN107320522A (en) | 2017-07-11 | 2017-07-11 | Chinese medicine composition and preparation method are grown for bird immunity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710560002.XA CN107320522A (en) | 2017-07-11 | 2017-07-11 | Chinese medicine composition and preparation method are grown for bird immunity |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107320522A true CN107320522A (en) | 2017-11-07 |
Family
ID=60196871
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710560002.XA Pending CN107320522A (en) | 2017-07-11 | 2017-07-11 | Chinese medicine composition and preparation method are grown for bird immunity |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107320522A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110141659A (en) * | 2019-06-10 | 2019-08-20 | 山东利邦牧业股份有限公司 | A kind of novel enhanced livestock and poultry Abwehrkraft des Koepers activity peptase and preparation method |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1704085A (en) * | 2004-06-04 | 2005-12-07 | 成都地奥制药集团有限公司 | Pharmaceutical composition with immunoregulation function and method for preparing the same |
CN103432443A (en) * | 2013-08-10 | 2013-12-11 | 安徽快康生物科技有限公司 | Traditional Chinese medicine composition for treating chicken infectious bursal disease |
CN103610738A (en) * | 2013-12-10 | 2014-03-05 | 济南三峰生物工程有限责任公司 | Traditional Chinese medicine particle for preventing and treating avian influenza and improving chicken flock immunity and preparation method thereof |
CN106344645A (en) * | 2016-10-09 | 2017-01-25 | 锦州医科大学 | Traditional Chinese medicine immunity enhancer suitable for poultry and preparation method thereof |
-
2017
- 2017-07-11 CN CN201710560002.XA patent/CN107320522A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1704085A (en) * | 2004-06-04 | 2005-12-07 | 成都地奥制药集团有限公司 | Pharmaceutical composition with immunoregulation function and method for preparing the same |
CN103432443A (en) * | 2013-08-10 | 2013-12-11 | 安徽快康生物科技有限公司 | Traditional Chinese medicine composition for treating chicken infectious bursal disease |
CN103610738A (en) * | 2013-12-10 | 2014-03-05 | 济南三峰生物工程有限责任公司 | Traditional Chinese medicine particle for preventing and treating avian influenza and improving chicken flock immunity and preparation method thereof |
CN106344645A (en) * | 2016-10-09 | 2017-01-25 | 锦州医科大学 | Traditional Chinese medicine immunity enhancer suitable for poultry and preparation method thereof |
Non-Patent Citations (3)
Title |
---|
仰榴青,等: "银杏外种皮多糖的免疫活性研究", 《时珍国医国药》 * |
尹卫卫,等: "复方四君子可溶性粉对肉用仔鸡免疫效果的影响", 《中国畜牧兽医》 * |
杨小燕,等: "银杏叶对肉鸡生长性能免疫功能和血清生化指标的影响", 《中国兽医杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110141659A (en) * | 2019-06-10 | 2019-08-20 | 山东利邦牧业股份有限公司 | A kind of novel enhanced livestock and poultry Abwehrkraft des Koepers activity peptase and preparation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102239972B (en) | Traditional Chinese medicine feed additive for improving immunity and anti-parasitic infection of weaned piglets and its preparation and use method | |
CN112568324B (en) | Composite probiotics fermented traditional Chinese medicine feed additive and preparation method and application thereof | |
CN102813064A (en) | Plant extract feed additive for piglets | |
CN112293603A (en) | Chinese herbal medicine additive for promoting growth of laying hens and improving egg quality and feeding method thereof | |
KR20150095708A (en) | Composition for preventing and treating cancer-related fatigue, containing processed ginseng powder or processed ginseng extract having increased ginsenoside constituent | |
JP6626035B2 (en) | Pharmaceutical composition for prevention or treatment of sarcopenia and health food composition for prevention or improvement | |
CN103340291B (en) | Chinese herbal feed modifier for improving meat quality of livestock and poultry and quality of fresh eggs | |
CN103083510A (en) | Chinese medicinal oral liquid for improving poultry immune function and its preparation method | |
CN104686806A (en) | Compound feed additive for enhancing broiler chicken immunity | |
CN105663546A (en) | Chinese traditional medicine composition for treating proventriculitis of chicken | |
CN104171336A (en) | Disease-resisting and growth-promoting eel feed and eel feed combined additive | |
CN112293604A (en) | Chinese herbal medicine additive for feeding laying hens and feeding method thereof | |
CN107961260A (en) | Treatment, the medicament for preventing birds coliform diarrhea disease and preparation method thereof | |
CN107320522A (en) | Chinese medicine composition and preparation method are grown for bird immunity | |
CN104546967A (en) | Composite venenum bufonis injection and preparation method thereof | |
Beski et al. | Effects of the addition of aqueous liquorice (Glycyrrhiza glabra) extract to drinking water in the production performance, carcass cuts and intestinal histomorphology of broiler chickens | |
CN107308248A (en) | A kind of Chinese herbal compound preparation beneficial to improving livestock and poultry production performance and preparation method thereof and application method | |
CN105770307B (en) | Traditional Chinese medicine composition for preventing and treating ascites syndrome of poultry, feed and application thereof | |
CN106344645B (en) | Traditional Chinese medicine immune enhancer for poultry and preparation method | |
CN116270887B (en) | Chinese medicinal composition for chicken and preparation method thereof | |
CN109170174A (en) | A kind of chicken feed addictive and its application, chicken feed | |
CN111544570B (en) | Antiviral preparation added with antibacterial peptide and preparation method thereof | |
CN117357627B (en) | Composite medicine for improving body immunity of poultry and preparation method and application thereof | |
CN117898395B (en) | Fermentation composition and its application in preparing products with laxative effect | |
CN115444877B (en) | Veterinary medicine for improving poultry disease resistance and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |